1. Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine
   Niraj Lodhi et al, 2020, Oncotarget CrossRef
2. Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer
   Rashed Pourhamidi et al, 2023, Journal of the Egyptian National Cancer Institute CrossRef
3. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex
   Hiresh Ayoubian et al, 2019, Journal of Virology CrossRef
4. Role of microRNA in Normal and Malignant Hematopoiesis
   Ruchi Gupta et al, 2019, Hematopathology CrossRef
5. Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma
   Gabrielle Bradshaw et al, 2016, Genes CrossRef
6. Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method
   Shan-Ju Yeh et al, 2022, International Journal of Molecular Sciences CrossRef
7. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study
   Francesco Marchesi et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
8. Targeting microRNA in hematologic malignancies
   Zhen Han et al, 2020, Current Opinion in Oncology CrossRef
9. Long Non-Coding RNAs Modulate Sjögren’s Syndrome Associated Gene Expression and Are Involved in the Pathogenesis of the Disease
   null Dolcino et al, 2019, Journal of Clinical Medicine CrossRef
10. MicroRNA profiling in canine multicentric lymphoma
    Karlee K. L. Craig et al, 2019, PLOS ONE CrossRef
11. Long noncoding RNA identification in lymphoma
    Gu Siyu et al, 2017, Future Oncology CrossRef
12. Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients
    Maogui Hu et al, 2021, Bioscience Reports CrossRef
13. Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP
    Nasrin Zare et al, 2019, Leukemia & Lymphoma CrossRef
14. Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma
    Qingyan Cui et al, 2018, Oncotarget CrossRef